Dynamic Choice HIV Prevention With Cabotegravir (CAB-LA): A Model-Based Cost-Effectiveness Analysis

Category Primary study
Conference2025 Conference on Retroviruses and Opportunistic Infections, CROI 2025
Year 2025
This article has no abstract
Epistemonikos ID: 04f55454893feadba1d0e42bc61f03a420cc03b7
First added on: Jun 15, 2026